Cell and Gene Therapy Catapult
- World rank, 2022–2025
- #17,515 of 28,054 · #20,148 all time
- Rank in United Kingdom
- #622 of 1,094
- Research works
- 245 ▲ 40% vs 2013–17
- Citations
- 7.7k 31.4 per fractional work
- Top-10% rate
- 21.0% record average 16.5%
- Open access
- 46% world 28%
What does Cell and Gene Therapy Catapult specialise in?
Where its research is concentrated relative to its size: Biochemistry, Genetics and Molecular Biology takes 6.7× the share of its output that it takes of world research.
- Biochemistry, Genetics and Molecular BiologyField · 21.4 works6.7×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.7×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 6.7×
- Immunology and Microbiology 4.7×
- Neuroscience 2.2×
- Medicine 1.8×
- Veterinary 1.0×
- Health Professions 0.7×
- Business, Management and Accounting 0.7×
- Economics, Econometrics and Finance 0.7×
- Engineering 0.5×
- Social Sciences 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Materials Science 0.3×
- Mathematics 0.2×
- Agricultural and Biological Sciences 0.2×
- Environmental Science 0.2×
- Computer Science 0.1×
- Chemistry 0.1×
- Arts and Humanities 0.1×
- Decision Sciences 0.0×
Which keywords describe research at Cell and Gene Therapy Catapult?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Regenerative Medicine, Immunotherapy, Cancer Immunotherapy, Glycosylation, Gene Therapy, Genome Engineering, RNA-Guided and Cell Culture.
- Synthetic Biology
- Monoclonal Antibodies
- Biomedical Engineering
- Reprogramming
- Induced Pluripotent Stem Cells
- Embryonic Stem Cells
- Pluripotent Stem Cells
- Differentiation
- Innovation
- Recombinant Protein
- Biopharmaceutical Production
- Transcriptional Regulation
- CAR T Cells
- Stem Cell Regulation
- Leukemia
- Lymphoma
- Cell Culture
- Genome Engineering
- Gene Therapy
- Immunotherapy
- Regenerative Medicine
- Cancer Immunotherapy
- Glycosylation
- RNA-Guided
- Clinical Trials
- Ethical Issues
- Regulatory Challenges
- Tumor Regression
- Chimeric Antigen Receptor
- Monoclonal Antibody
- Mammalian Cells
- Education
- Oxidative Stress
- Healthcare
- AAV
- Genomic Integration
- Macular Degeneration
- Viral Vectors
- Hackathons
- Therapeutic Antibodies
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Regenerative Medicine4▲ 26×3 topics
- Immunotherapy4▲ 8.8×8 topics
- Cancer Immunotherapy4▲ 40×3 topics
- Gene Therapy4▲ 30×4 topics
- Glycosylation4▲ 53×2 topics
- Genome Engineering3▲ 84×1 topic
- RNA-Guided3▲ 84×1 topic
- Cell Culture3▲ 47×2 topics
- Clinical Trials3▲ 7.9×3 topics
- Lymphoma3▲ 33×3 topics
- Ethical Issues3▲ 48×2 topics
- Leukemia3▲ 60×2 topics
- Regulatory Challenges3▲ 57×1 topic
- Stem Cell Regulation3▲ 223×1 topic
- Tumor Regression3▲ 45×2 topics
- CAR T Cells3▲ 65×1 topic
- Chimeric Antigen Receptor3▲ 65×1 topic
- Transcriptional Regulation3▲ 29×5 topics
- Monoclonal Antibody3▲ 82×2 topics
- Biopharmaceutical Production2▲ 98×2 topics
- Mammalian Cells2▲ 169×1 topic
- Recombinant Protein2▲ 169×1 topic
- Education2▲ 2.2×4 topics
- Innovation2▲ 3.6×2 topics
- Oxidative Stress2▲ 2.4×15 topics
- Differentiation2▲ 56×2 topics
- Healthcare2▲ 2.9×2 topics
- Pluripotent Stem Cells2▲ 65×2 topics
- AAV2▲ 78×1 topic
- Embryonic Stem Cells2▲ 74×2 topics
- Genomic Integration2▲ 55×2 topics
- Induced Pluripotent Stem Cells2▲ 122×1 topic
- Macular Degeneration2▲ 26×3 topics
- Reprogramming2▲ 122×1 topic
- Viral Vectors2▲ 78×1 topic
- Biomedical Engineering2▲ 20×1 topic
- Hackathons2▲ 82×1 topic
- Monoclonal Antibodies2▲ 31×3 topics
- Therapeutic Antibodies2▲ 40×2 topics
- Synthetic Biology1▲ 37×2 topics
Which research topics does Cell and Gene Therapy Catapult publish most on?
By volume in 2022–2025: CRISPR and Genetic Engineering, Biomedical Ethics and Regulation, CAR-T cell therapy research and Viral Infectious Diseases and Gene Expression in Insects.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CRISPR and Genetic Engineering Molecular Biology 3 works
- 2 Biomedical Ethics and Regulation Physiology 3 works
- 3 CAR-T cell therapy research Oncology 3 works
- 4 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 2 works
- 5 Virus-based gene therapy research Genetics 2 works
- 6 Pluripotent Stem Cells Research Molecular Biology 2 works
- 7 Biomedical and Engineering Education Biomedical Engineering 2 works
- 8 Retinal Development and Disorders Molecular Biology 1 works
- 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 10 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Cell and Gene Therapy Catapult's research output changed?
Output in 2018–2022 was 40% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in London
- University College London
- Imperial College London
- King's College London
- Queen Mary University of London
- London School of Economics and Political Science
- University of London
- Brunel University of London
- London School of Hygiene & Tropical Medicine
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.